[Federal Register Volume 62, Number 215 (Thursday, November 6, 1997)]
[Notices]
[Pages 60096-60097]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-29365]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Purusant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting of the National Cancer Institute, Frederick Cancer Research and
Development Center Advisory Committee.
The open portion of the meeting will be limited to space available.
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations, should
notify the contact person in advance of the meeting.
Committee Name: Frederick Cancer Research and Development Center
Advisory Committee.
Date: December 11-12, 1997.
Palce: Frederick Cancer Research and Development Center,
Building 549, Executive Board Room, Frederick, Maryland 21702-1201.
Open: December 11--8:30 a.m.-10:00 a.m..
Agenda: Discussion of administrative matters such as future
meetings, budget, and information items related to the operation of
the NCI Frederick Cancer Research and Development Center.
Closed: December 11--10 a.m. to recess, December 12-8:30 a.m. to
adjournment.
Agenda/Purpose: Discussion of previous site visit report and
response for the Gene Regulation and Chromosome Biology Laboratory
and Molecular Aspects of Drug Design Section both under contract
with ABL--Basic Research Program review held June 9-10, 1997. The
majority of the closed session will be devoted to a site review of
the Molecular Basis of Carcinogenesis Laboratory with ABL--Basic
Research Program contract.
Contact Person: Donald F. Summers, M.D., Acting Executive
Secretary, Frederick Cancer Research and Development Center, P.O.
Box B, Frederick, MD 21702-1201, Telephone: 301-846-5096.
The meeting will be closed in accordance with the provisions set
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. The
[[Page 60097]]
report and the discussions could reveal confidential trade secrets
or commercial property such as patentable material and personal
information concerning individual associated with the programs,
disclosure of which would constitute a clearly unwarranted invasion
of personal privacy.
(Catalog Of Federal Domestic Assistance Program Numbers: 93.393,
Cancer Cause and Prevention Research, 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer Treatment Research, 93.396,
Cancer Biology Research; 93.397, Cancer Centers Support; 93.398,
Cancer Research Manpower; 93,399, Cancer Control)
Dated: October 30, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-29365 Filed 11-5-97; 8:45 am]
BILLING CODE 4140-01-M
